New Acebutolol Therapy Findings from Department of Bio and Brain Engineering Described (Acebutolol, a Cardioselective Beta Blocker, Promotes Glucose Uptake in Diabetic Model Cells by Inhibiting JNK-JIP1 Interaction)

Source :: Diabetes Week. November 27, 2017, 269
Publication Year :: 2017
Abstract: 2017 NOV 27 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Data detailed on Drugs and Therapies - Acebutolol Therapy have been presented. According to news [...]

Subjects :: Glucose -- Models
Glucose metabolism -- Models
Type 2 diabetes -- Research -- Drug therapy -- Models
Diabetes therapy -- Models
Insulin resistance -- Research -- Drug therapy -- Models
Brain research -- Models
Acebutolol -- Research -- Models
Health

Tools